Post Operative Troponin Leak: David Smyth Christchurch New Zealand
|
|
- Barbra Leonard
- 6 years ago
- Views:
Transcription
1 Post Operative Troponin Leak: Does It Really Matter? David Smyth Christchurch New Zealand
2 Life Was Simple Once Transmural Infarction Subendocardial Infarction
3 But the Blood Tests Were n t Perfect Creatine Kinase Heart and Skeletal Muscle Aspartate Transaminase Heart and Liver Lactate Dehydrogenase Heart, Brain, Red Cell
4 Cardiac Troponins (ctn) Structural Proteins of the Contractile Apparatus of Skeletal and Myocardial Myocytes. Three subunits: T (TnT), I (TnI), and C (TnC). Skeletal and Cardiac Myocyte Isoforms of TnI and TnT are different Allows for high specificity in the measurement of the cardiac forms (the cardiac troponins, ctn). High sensitivity Tests Have Been Introduced into Clinical Practice
5 Cardiac Troponins (ctn) as Biomarkers Biphasic Release Kinetics Following Injury Initially Myocardial Cell Damage Releases Unbound Cytosolic ctn Detectable 4-6h After Insult Peaks at 12-24h Structural Proteins Released 2-4 Days After Injury Continuing Breakdown of Myofibrillary-Bound Complex Persists for up to 14 days after Injury CK-MB Better to Diagnose Recurrent Injury (infarction) However detectable increases ctn Indicate Myocardial Injury Do Not Imply Mechanism of Injury Can Not (in isolation) be used to Diagnose Acute Myocardial Infarction
6 Release Kinetics of Myocardial Injury Markers
7 Post Operative Cardiac Mortality 1977 Goldman Risk Evaluation System (1001 Patients Undergoing Surgery) 22% rate of life-threatening cardiovascular events >50% mortality in the highest-risk group 2011 Finks et al. 2.8% National Mortality Rate for Open Abdominal Aortic Aneurysm repair Fall in Mortality is Incremental: Advances in Anaesthetic Technique Surgical Technique Perioperative Medical Treatment Could High ctn Monitoring Help Reduce it Further? Goldman et al. N Engl J Med. 1977;297: Finks et al. N Engl J Med. 2011;364:
8 Revised Definition of MI from the European Society of Cardiology/American College of Cardiology One of the following: Increase and/or decrease of biochemical markers of myocardial necrosis Troponin Creatine kinase MB isoenzyme Plus at least one of the following: Ischaemic symptoms Development of pathological Q waves on the ECG ECG changes indicative of ischaemia Acute Coronary Stenosis / Occlusion at Angiography Pathological findings of Acute MI Five Main Groups of Myocardial Infarction Type 1: infarction Spontaneous myocardial Type 2: Myocardial infarction secondary to an ischaemic imbalance Type 3: Myocardial infarction resulting in death when biomarker values are unavailable Type 4a: Myocardial infarction related to percutaneous coronary intervention (PCI) Type 4b: Myocardial infarction related to stent thrombosis Type 5: Myocardial infarction related to coronary artery bypass grafting (CABG) Alpert et al. J Am Coll Cardiol 2000; 36:
9 Why Might Surgery Cause Increased ctn? It May Already Be Raised Stress of Surgery May Rupture Plaque and Cause Acute Infarction Supply-Demand Imbalance: Transient AF / Perioperative Hypotension Something Else Pulmonary Embolism Myo-Pericarditis Multi-Organ Inflammatory State Sepsis
10 Why Might Surgery Cause Increased ctn? It May Already Be Raised Stress of Surgery May Rupture Plaque and Cause Acute Infarction Supply-Demand Imbalance: Transient AF / Perioperative Hypotension Something Else Pulmonary Embolism Myo-Pericarditis Multi-Organ Inflammatory State Sepsis
11 Dallas Heart Study: HScTnT in Healthy Individuals ctnt Measured in 3546 Individuals aged 30 to 65 years between 2000 and 2002 in Dallas County Prevalence of Detectable HScTnT (0.003ng/mL) was 25.0% de Lemos et al. JAMA. 2010;304(22):
12 Dallas Heart Study: HScTnT in Healthy Individuals ctnt Measured in 3546 Individuals aged 30 to 65 years between 2000 and 2002 in Dallas County Prevalence of Detectable HScTnT (0.003ng/mL) was 25.0% de Lemos et al. JAMA. 2010;304(22):
13 patients The Vascular Events In Non Cardiac Surgery (VISION) Study TnT levels were Measured 6-12h Post Surgery Repeated on days 1, 2, and 3 30-day mortality rate was 1.9% (95% CI, 1.7%-2.1%) Conclusion Among Patients Undergoing Non Cardiac Surgery, Peak Postoperative TnT in the First 3 days after Surgery was Significantly Associated with 30-Day Mortality VISION Study Investigators JAMA. 2012;307:
14 VISION Study Investigators JAMA. 2012;307: VISION Study: Predictors of Cardiac and Non Cardiac Risk
15 Why Might Surgery Cause Increased ctn? It May Already Be Raised Stress of Surgery May Rupture Plaque and Cause Acute Infarction Supply-Demand Imbalance: Transient AF / Perioperative Hypotension Something Else Pulmonary Embolism Myo-Pericarditis Multi-Organ Inflammatory State Sepsis
16 Will β-blockers Help?: The POISE Trial Primary End Point: Cardiac Death, MI, Stroke 8351 Patients With or at Risk of Atherosclerosis Disease Undergoing Non-Cardiac Surgery Metoprolol (n=4174) or placebo (n=4177) Started 2 4 h before surgery and continued for 30 days p= % 5 8% Devereaux et al. Lancet 2008; 371:
17 Will β-blockers Help?: The POISE Trial MI 8351 Patients With or at Risk of Atherosclerosis Disease Undergoing Non-Cardiac Surgery Metoprolol (n=4174) or placebo (n=4177) Started 2 4 h before surgery and continued for 30 days p= % 4.2% Devereaux et al. Lancet 2008; 371:
18 Will β-blockers Help?: The POISE Trial Stroke 8351 Patients With or at Risk of Atherosclerosis Disease Undergoing Non-Cardiac Surgery Metoprolol (n=4174) or placebo (n=4177) Started 2 4 h before surgery and continued for 30 days p= % 0.5% Devereaux et al. Lancet 2008; 371:
19 Will β-blockers Help?: The POISE Trial Total Death 8351 Patients With or at Risk of Atherosclerosis Disease Undergoing Non-Cardiac Surgery Metoprolol (n=4174) or placebo (n=4177) Started 2 4 h before surgery and continued for 30 days p= % 2.3% Devereaux et al. Lancet 2008; 371:
20 Criticisms of POISE Iranian Hospitals Aggressive β-blockade Metoprolol 200mg/Day HR 55 Systolic BP 100mmHg Aggrevate Effects of Post Operative Sepsis For Every 1000 Treated, Extended Release Metoprolol Resulted in an Excess of: 8 deaths 5 Patients With a Stroke 53 Clinically Significant Hypotension 42 Clinically significant bradycardia Devereaux et al. Lancet 2008; 371:
21 What About Aspirin? POISE 2 10,010 Patients Undergoing Non Cardiac surgery With Increased Risk of Vascular Complications Primary Endpoint 2x2 Randomised Trial: Aspirin+/- Clonidine+/- Placebo No PreExisting Aspirin Therapy Initiation Stratum: 5628 patients Chronic Aspirin Therapy Continuation stratum: 4382 Patients Started Immediately Pre Operatively (200mg) Continued for 30 Days (100mg) Primary Outcome Composite of Death or Nonfatal Myocardial Infarction at 30 days Devereaux et al. N Engl J Med 2014;370:
22 What About Aspirin? POISE 2 10,010 Patients Undergoing Non Cardiac surgery With Increased Risk of Vascular Complications 2x2 Randomised Trial: Aspirin+/- Clonidine+/- Placebo No PreExisting Aspirin Therapy Initiation Stratum: 5628 patients Chronic Aspirin Therapy Continuation stratum: 4382 Patients Started Immediately Pre Operatively (200mg) Continued for 30 Days (100mg) Primary Outcome Composite of Death or Nonfatal Myocardial Infarction at 30 days Devereaux et al. N Engl J Med 2014;370:
23 What About Aspirin? POISE 2 Major Bleeding 10,010 Patients Undergoing Non Cardiac surgery With Increased Risk of Vascular Complications 2x2 Randomised Trial: Aspirin+/- Clonidine+/- Placebo No PreExisting Aspirin Therapy Initiation Stratum: 5628 patients Chronic Aspirin Therapy Continuation stratum: 4382 Patients Started Immediately Pre Operatively (200mg) Continued for 30 Days (100mg) Increased Risk Of Bleeding Primary Outcome Composite of Death or Nonfatal Myocardial Infarction at 30 days Devereaux et al. N Engl J Med 2014;370:
24 Why Might Surgery Cause Increased ctn? It May Already Be Raised Stress of Surgery May Rupture Plaque and Cause Acute Infarction Supply-Demand Imbalance: Transient AF / Perioperative Hypotension Something Else Pulmonary Embolism Myo-Pericarditis Multi-Organ Inflammatory State Sepsis
25 What About Clonidine? POISE 2 10,010 Patients Undergoing Non Cardiac surgery With Increased Risk of Vascular Complications 2x2 Randomised Trial: Aspirin+/- Clonidine+/- Placebo Clonidine Started Immediately Pre Operatively (0.2mg) Continued for 72h Primary Outcome Composite of Death or Nonfatal Myocardial Infarction at 30 days Primary Endpoint Devereaux et al. N Engl J Med 2014;370:
26 What About Clonidine? POISE 2 10,010 Patients Undergoing Non Cardiac surgery With Increased Risk of Vascular Complications 2x2 Randomised Trial: Aspirin+/- Clonidine+/- Placebo Clonidine Started Immediately Pre Operatively (0.2mg) Continued for 72h Primary Outcome Composite of Death or Nonfatal Myocardial Infarction at 30 days Devereaux et al. N Engl J Med 2014;370:
27 Conundra Who Should Be Targeted? Everyone Only Those at High risk What Should We Do About It? Are There Harmful Consequences In Some?
28 VISION Study Investigators JAMA. 2012;307: VISION Study: Predictors of Cardiac and Non Cardiac Risk
29 VISION Study: Predictors of Cardiac and Non Cardiac Risk Age VISION Study Investigators JAMA. 2012;307:
30 VISION Study: Predictors of Cardiac and Non Cardiac Risk Age VISION Study Investigators JAMA. 2012;307:
31 VISION Study: Predictors of Cardiac and Non Cardiac Risk Risks VISION Study Investigators JAMA. 2012;307:
32 VISION Study: Predictors of Cardiac and Non Cardiac Risk Risks VISION Study Investigators JAMA. 2012;307:
33 VISION Study: Predictors of Cardiac and Non Cardiac Risk Surgery VISION Study Investigators JAMA. 2012;307:
34 VISION Study: Predictors of Cardiac and Non Cardiac Risk Surgery VISION Study Investigators JAMA. 2012;307:
35 VISION Study: Predictors of Cardiac and Non Cardiac Risk ctn VISION Study Investigators JAMA. 2012;307:
36 VISION Study: Predictors of Cardiac and Non Cardiac Risk ctn VISION Study Investigators JAMA. 2012;307:
37 Will Revascularisation Help? BARI 2D: Troponin Substudy 2368 Patients Who Had Both Type 2 Diabetes and Stable Ischaemic Heart Disease with Mild/No Symptoms Randomised to either Prompt Revascularisation (PCI or CABG) vs Optimal Medical Therapy Troponin T Measured at Baseline 2277 (99.6%) had detectable ( 3 ng/l) troponin T concentrations 897 (39.3%) had abnormal troponin T concentrations at baseline ( 14 ng/l) Primary Endpoint: Cardiac Death, Stroke, MI Everett et al. N Engl J Med 2015;373:610-20
38 Will Revascularisation Help? BARI 2D: Troponin Substudy 2368 Patients Who Had Both Type 2 Diabetes and Stable Ischaemic Heart Disease with Mild/No Symptoms Randomised to either Prompt Revascularisation (PCI or CABG) vs Optimal Medical Therapy Troponin T Measured at Baseline 2277 (99.6%) had detectable ( 3 ng/l) troponin T concentrations 897 (39.3%) had abnormal troponin T concentrations at baseline ( 14 ng/l) All Cause Mortality Everett et al. N Engl J Med 2015;373:610-20
39 How To Deal With an Elevated Post Operative ctn Start Early: Check Pre Surgery ctn >65 Major Surgery Neurosurgery Stratify Risk with Worst case Scenario DES Ensure Patients with High Cardiovascular Risk are on appropriate Therapy Statins Β Blockers (?) Post Op?Clinical Evidence of Acute Myocardial Infarction Symptoms (?) ECG Consider Echo Wall Motion Abnormality Overall LV Function If Abnormal: Consider Angiography and Revascularisation if Appropriate Low Dose Aspirin (?)
Peri-operative Troponin Measurements - Pathophysiology and Prognosis
Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory
More informationPerioperative Infarcts: Epidemiology, predictors and post-op monitoring
Friday Nov 3rd, 2017 1pm Perioperative Infarcts: Epidemiology, predictors and post-op monitoring Dr Carol Chong Geriatrician Northern Health, Epping, Victoria, Australia How I became interested in this
More informationPERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW
PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research
More informationClinical Controversies in Perioperative Medicine
Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive
More informationChest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham
Chest pain and troponins on the acute take J N Townend Queen Elizabeth Hospital Birmingham 3 rd Universal Definition of Myocardial Infarction Type 1: Spontaneous MI related to atherosclerotic plaque rupture
More informationValue of troponin measurements in carotid artery revascularization
Value of troponin measurements in carotid artery revascularization Gert J de Borst Department of Vascular Surgery Postoperative myocardial infarction after NCS: Magnitude of the problem POISE-1: 367 /8,351=
More informationBIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.
BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS As. MARUSHCHAK M.I. Heart attack symptoms Acute MI Measurement of cardiac enzyme levels Measure cardiac enzyme levels at regular
More informationEssam Mahfouz, MD. Professor of Cardiology, Mansoura University
By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part
More informationMyocardial injury, necrosis and infarction
Myocardial injury, necrosis and infarction Harvey White Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Faculty Disclosure In accordance
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationAcute coronary syndromes
Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.
More informationThe Universal Definition of Myocardial Infarction 3 rd revision, 2012
The Universal Definition of Myocardial Infarction 3 rd revision, 2012 Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ; Editor-in-Chief, American Journal
More informationTopic. Updates on Definition of Myocardial Infarction
Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical
More informationCardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology
Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations
More informationPreoperative Cardiac Evaluation:
Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationChallenging Issues in Cardiac Biomarker interpretation. F. Nikaeen. MD interventional Cardiologist
Challenging Issues in Cardiac Biomarker interpretation F. Nikaeen. MD interventional Cardiologist Biomarkers Types of Troponin Troponin C Binds calcium Troponin I Binds actin Troponin T Binds tropomyosin
More informationAgenda. Disclosures. Surgical Mortality: What is High Risk?
Pre-Operative Cardiac Evaluation of the Vascular Patient: Updated AHA/ACC Guidelines Choosing Wisely UCSF Vascular Symposium 2015 Joshua A. Beckman, M.D., M.S. Brigham and Women s Hospital Consulting Merck
More informationBIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION. Written by Lenka Fialová, translated by Jan Pláteník
BIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION 1 Structure of heart muscle Written by Lenka Fialová, translated by Jan Pláteník Heart muscle (myocardium) is a particular form of striated muscle,
More informationUPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment
More informationSESSION 5 2:20 3:35 pm
SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:
More informationTROPONINS HAVE THEY CHANGED YOUR
TROPONINS HAVE THEY CHANGED YOUR PRACTICE THIS WEEK? Harvey White John Neutze Scholar Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Disclosure
More informationTYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016
TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationIschemic Heart Disease
Ischemic Heart Disease Dr Rodney Itaki Lecturer Division of Pathology University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Consideration Results from partial
More informationPrehospital and Hospital Care of Acute Coronary Syndrome
Ischemic Heart Diseases Prehospital and Hospital Care of Acute Coronary Syndrome JMAJ 46(8): 339 346, 2003 Katsuo KANMATSUSE* and Ikuyoshi WATANABE** * Professor, Second Internal Medicine, Nihon University,
More informationGuidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct
PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac
More informationMedicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
More informationAbout OMICS International
About OMICS International OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700
More informationPerioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality
Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality Art Wallace, MD, PhD SF VAMC Chief of Anethesia and Vice Chair of Anesthesia and Perioperative Care UCSF
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More information(For items 1-12, each question specifies mark one or mark all that apply.)
Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:
More informationHow will new high sensitive troponins affect the criteria?
How will new high sensitive troponins affect the criteria? Hugo A Katus MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Even more sensitive: The new
More informationTROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?
TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific
More informationPost-Procedural Myocardial Injury or Infarction
Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:
More informationDual Antiplatelet Therapy Made Practical
Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationEvaluating the Heart before Non-Cardiac Surgery
Evaluating the Heart before Non-Cardiac Surgery Dr Rob Stephens Anaesthetist UCLH + UCL the centre for Anaesthesia www.ucl.ac.uk/anaesthesia/people/stephens Google UCL Stephens www.ucl.ac.uk/anaesthesia/people/stephens
More informationREVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands
REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands TRITON Prasugrel ACS + PCI n = 13,608 moderate / high risk ACS, all PCI p
More informationQUT Digital Repository:
QUT Digital Repository: http://eprints.qut.edu.au/ This is the author s version of this journal article. Published as: Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes.
More informationRole of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
More informationHigh Sensitivity Troponin Improves Management. But Not Yet
High Sensitivity Troponin Improves Management But Not Yet Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine
More informationAIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection
CHEST PAIN Dr Susan Hertzberg Emergency Department Prince of Wales Hospital AIMS: To identify causes of chest pain in patients presenting to the ED. To identify and risk stratify patients presenting with
More informationBiomarkers of myocardial infarction. Dr. Mamoun Ahram Cardiovascular system, 2013
Biomarkers of myocardial infarction Dr. Mamoun Ahram Cardiovascular system, 2013 References This lecture Hand-outs Acute Myocardial Infarction A rapid development of myocardial necrosis caused by prolonged
More informationCardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray
Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe the acute
More informationPACT module High risk surgical patient. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module High risk surgical patient Intensive Care Training Program Radboud University Medical Centre Nijmegen Intravascular volume effect of Ringer s lactate Double-tracer BV measurement Blood 1097
More informationCoding an Acute Myocardial Infarction: Unravelling the Mystery
Coding an Acute Myocardial Infarction: Unravelling the Mystery by Karen Carr, MS, BSN, RN, CCDS, CDIP, and Lisa Romanello, MSHI, BSN, RN, CCDS, CDIP WHITE PAPER Summary: The following white paper offers
More informationPerioperative Myocardial Infarction
Perioperative Myocardial Infarction Which patient should UNDERGO CORONARY ANGIOGRAPHY? The Cardiologists view Hans Rickli, St.Gallen 1 Experience Standards Risk stratification Team approach.. Tightrope
More information1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).
1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 5- cardiogenic shock (massive MIs >40% of the left ventricle)
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationSTEMI AND MULTIVESSEL CORONARY DISEASE
STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationFastTest. You ve read the book now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
More informationChest pain management. Ruvin Gabriel and Niels van Pelt August 2011
Chest pain management Ruvin Gabriel and Niels van Pelt August 2011 Introduction Initial assessment Case 1 Case 2 and 3 Comparison of various diagnostic techniques Summary 1-2 % of GP consultations are
More informationWhat is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital
What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction? THEY AINT WHAT THEY USED TO BE Case
More informationCoronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationPerioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease
2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with
More informationFourth Universal Definition of Myocardial Infarction (2018)
EUSEM, Glasgow 2018 Fourth Universal Definition of Myocardial Infarction (2018) Univ.-Prof. Dr. Martin Möckel, Division of Emergency and Acute Medicine, Charité Universitätsmedizin Berlin 2 1 History of
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationControversies in Perioperative Medicine
Controversies in Perioperative Medicine Staying Abreast & Ahead of the Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Controversies in Perioperative
More informationHigh Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.
High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr. Marcel El Achkar Chairperson of Laboratory department Nini Hospital Lecturer
More informationSTEMI and Cardiogenic Shock. The rules and solution. Dave Kettles St Dominics and Frere Hospitals East London ZA
STEMI and Cardiogenic Shock. The rules and solution Dave Kettles St Dominics and Frere Hospitals East London ZA Definitions: Shock is a life threatening, but initially reversible state of cellular and
More informationMaster Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Coronary interventions in patients with diabetes Lars Rydén Karolinska Institutet Stockholm, Sweden
More informationUpdate on Perioperative Medicine. Update on Perioperative Medicine. Question 1: Clinical Risk Prediction. for the Office-based Practitioner
Update on Perioperative Medicine Update on Perioperative Medicine for the Office-based Practitioner Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting
More informationInternationally indexed journal
www.ijpbs.net Internationally indexed journal Indexed in Chemical Abstract Services (USA), Index coppernicus, Ulrichs Directory of Periodicals, Google scholar, CABI,DOAJ, PSOAR, EBSCO, Open J gate, Proquest,
More informationPractitioner Education Course
2015 Practitioner Education Course ST Elevation Myocardial Infarction 2 Pathology Concept of vulnerable plaque Mild Atheroma Diagnosis IVUS OCT 3 Diagnosis This is based on : Clinical History ECG Changes.
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationOtamixaban for non-st-segment elevation acute coronary syndrome
Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationACUTE MYOCARDIAL INFARCTION: DEFINITION, DIAGNOSIS, AND THE EVOLUTION OF CARDIAC MARKERS
ACUTE MYOCARDIAL INFARCTION: DEFINITION, DIAGNOSIS, AND THE EVOLUTION OF CARDIAC MARKERS d Copyright 2018 by. LEARNING OBJECTIVES: 1. Define MI and the challenges in MI diagnosis 2. Define the current
More informationA Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in Patients with Non-ST Elevation ACS
Angioplasty to Blunt the rise Of troponin in Acute coronary syndromes Randomized for an immediate or Delayed intervention A Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in
More informationAgenda. Perioperative Cardiac Risk Stratification circa Surgical Mortality: What is High Risk? Presenter Disclosure Information
9:45 1:45 am Perioperative Evaluation and Management of the Cardiac Patient in Noncardiac Surgery SPEAKER Joshua A. Beckman, MD, MS Presenter Disclosure Information The following relationships exist related
More informationObjectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?
Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation
More informationMyocardial infarction
CHAPTER-I CARDIOVASCULAR SYSTEM Myocardial infarction SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. Venugopal Pharm.D Assistant Professor Department of Pharm.D Kriahna Teja Pharmacy College,Tirupati. Definition
More informationWhy and How Should We Switch Clopidogrel to Prasugrel?
Case Presentation Why and How Should We Switch Clopidogrel to Prasugrel? Shaul Atar Western Galilee Medical Center Nahariya, ISRAEL Case Description A 67 Y. Old Pt. admitted to IM with anginal CP. DM,
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationOvercoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD
Overcoming the Risk-Treatment Paradox in Non-STE ACS: It s Time! Christopher Granger, MD Disclosures Research contracts: AstraZeneca, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company,
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
More informationManaging Acute Coronary Syndromes
Managing Acute Coronary Syndromes Harvey White Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Managing Acute Coronary Syndromes Background
More informationNew universal definition of myocardial infarction
New universal definition of myocardial infarction L. K. Michalis, ΜRCP, FESC Professor of Cardiology, University of Ioannina Changing Criteria for definition of MI Primarily clinical & ECG approach First
More information9/18/2017. Disclosures. Cardiac Troponin: ER Utilization and the Next Generation
Disclosures Cardiac Troponin: ER Utilization and the Next Generation Joshua Soldo is an employee of Roche Diagnostics within the division of Medical Scientific Affairs. Data presented is intended for purely
More informationStatistical Analysis Plan
The BALANCED Anaesthesia Study A prospective, randomised clinical trial of two levels of anaesthetic depth on patient outcome after major surgery Protocol Amendment Date: November 2012 Statistical Analysis
More informationFifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012
Fifty shades of Troponin Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012 Plaque-fissure and intracoronary thrombus Courtesy Prof. MJ Davies Acute Coronary Syndromes Plaque-fissure and intracoronary
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationPreoperative Cardiac Risk Assessment: Approach & Guidelines
Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationManagement of the coronary patient in Roberto Ferrari
Management of the coronary patient in 2011 Roberto Ferrari What is new in treatment of stable CAD? In the era of interventional cardiology, is chronic stable angina a rare disease? Stable angina pectoris
More informationJournal of the American College of Cardiology Vol. 40, No. 6, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 40, No. 6, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02119-8
More informationM/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #
Acute Coronary Syndrome - Case Review - Young-Guk Ko, MD Yonsei Cardiovascular Center Yonsei University College of Medicine Case 1 M/39 #4306212 CC D : Severe squeezing chest pain : 4 hours, aggravated
More informationPRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London
PRE Operative Care of the High Risk Surgical Patient Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London Perioperative Optimization Shoemaker oxygen delivery goal directed therapy ITS NOT
More informationThe Clinical Laboratory Working with Physicians to Improve Patient Care
The Clinical Laboratory Working with Physicians to Improve Patient Care Michael A. Pesce, PhD Professor Emeritus Columbia University Medical Center Department of Pathology and Cell Biology Objectives Troponin
More informationAcute coronary syndrome (ACS) is a potentially
DIAGNOSING ACUTE CORONARY SYNDROME AND DETERMINING PATIENT RISK Edith A. Nutescu, PharmD* ABSTRACT Acute coronary syndrome is a form of coronary artery disease and has a broad range of clinical presentations.
More informationMR Assessment of Myocardial Viability
MR Assessment of Myocardial Viability Definition of Viability Clinical Metabolism: Presence of glucose uptake Perfusion / Perfusion reserve Morphology: Wall thickness, wall thickening Contractility: Recovery
More information